CIK 0001729427
- Non-accelerated filer
- Smaller reporting company
CNS Pharmaceuticals, Inc.
Sign in to watch- Ticker
- CNSP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 822318545
- Phone
- +1 800-946-9185
- Business address
- 2100 WEST LOOP SOUTH, SUITE 900, HOUSTON, TX, 77027
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Financial Officer acquired 33,000 shares (grant or award)
- 4 Grant or award Director acquired 11,100 shares (grant or award)
- 4 Grant or award Director acquired 3,750 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 35,000 shares (grant or award)
- 4 Other disposition 10% owner disposed of 1,495,867 shares (other)
- 4 Open-market buy Chief Financial Officer bought 5,000 shares at $0.94 ($4,702)
- 4 Open-market buy Chief Financial Officer bought 4,500 shares at $1.15 ($5,192)
- 4 Grant or award Chief Executive Officer acquired 5,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Financial Officer bought 142,000 shares at $2.04 ($289,680)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 4 of 5 · 90 filings